based on lawsuits, they don't want compounding as an optionThey are probably gearing up production so that a shortage doesn't exist at launch and compounding is allowed like with tirz.
And I am quite thankful for this. This benefits us quite a bit.They're too busy deleting tik tok accounts of anyone who mention the word "retatrutide" LOL
While I'm not a fan of censorship, I agree !!And I am quite thankful for this. This benefits us quite a bit.
Can you tell me why?And I am quite thankful for this. This benefits us quite a bit.
It's safer for them to do so after it's FDA approved. Any positive statements that they make now have the potential to temporarily raise the stock price now but lower it when the drug doesn't quite match that positive statement.I wonder why Lilly isn’t mentioning Reta in recent news releases about drugs in the pipe line